Abstract
Fragile X syndrome is the most common inherited form of mental retardation and is due to the silencing of FMR1 gene coding for the FMRP protein. FMRP is an RNA binding protein endowed with Nuclear Localization and Nuclear Export Signals and is associated with actively translating polysomes as part of mRNP complexes. During the past years, efforts from many laboratories to unravel the function of this protein, resulted in the identification of several proteins (mostly RNA-binding) and few hundred of mRNAs that are targeted by FMRP. The puzzle illustrating the FMRP role depicts a protein implicated in different steps of mRNA metabolism. However, its precise mechanism of action is not still understood and the specificity of its function is probably dependent on RNA and/or proteins that interact and associate with it.
Keywords: Fragile X syndrome, mental retardation, RNA-binding domains, RNA-binding proteins, mRNP-complexes, G-quartet, kissing-complex, Rac pathway
Current Genomics
Title: Fragile X Mental Retardation Protein: Many Partners and Multiple Targets for a Promiscuous Function
Volume: 6 Issue: 7
Author(s): E. W. Khandjian, E. Bechara, L. Davidovic and B. Bardoni
Affiliation:
Keywords: Fragile X syndrome, mental retardation, RNA-binding domains, RNA-binding proteins, mRNP-complexes, G-quartet, kissing-complex, Rac pathway
Abstract: Fragile X syndrome is the most common inherited form of mental retardation and is due to the silencing of FMR1 gene coding for the FMRP protein. FMRP is an RNA binding protein endowed with Nuclear Localization and Nuclear Export Signals and is associated with actively translating polysomes as part of mRNP complexes. During the past years, efforts from many laboratories to unravel the function of this protein, resulted in the identification of several proteins (mostly RNA-binding) and few hundred of mRNAs that are targeted by FMRP. The puzzle illustrating the FMRP role depicts a protein implicated in different steps of mRNA metabolism. However, its precise mechanism of action is not still understood and the specificity of its function is probably dependent on RNA and/or proteins that interact and associate with it.
Export Options
About this article
Cite this article as:
Khandjian W. E., Bechara E., Davidovic L. and Bardoni B., Fragile X Mental Retardation Protein: Many Partners and Multiple Targets for a Promiscuous Function, Current Genomics 2005; 6 (7) . https://dx.doi.org/10.2174/138920205775067701
DOI https://dx.doi.org/10.2174/138920205775067701 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advances in Genomics and Precision Medicine for Cardiovascular Diseases
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality globally, representing a significant challenge to public health systems. Recent advancements in genomics and precision medicine offer unprecedented opportunities to transform the prevention, diagnosis, and treatment of CVDs. This special issue of Current Genomics explores the latest developments in ...read more
AI-Driven Genomics and Multi-Omics Approaches for Drug Discovery and Precision Medicine
The rapid advancements in artificial intelligence (AI) have opened new avenues in genomics and multi-omics research, providing transformative insights into disease mechanisms, biomarker discovery, and therapeutic strategies. This thematic issue explores the intersection of AI with genomics, transcriptomics, proteomics, metabolomics, and epigenomics, focusing on how computational intelligence can facilitate data ...read more
Emerging Molecular Mechanisms in Rare Genetic Skeletal Disorders: Linking Genomic Mutations to Clinical Outcomes.
Rare genetic skeletal disorders encompass a diverse group of conditions that impact bone and cartilage development, often due to pathogenic mutations in critical developmental genes. This thematic issue aims to explore the intricate molecular mechanisms underlying these disorders, providing insights into how specific genomic mutations translate into clinical phenotypes. Recent ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Understanding Genotypes and Phenotypes of the Mutations in Voltage- Gated Sodium Channel α Subunits in Epilepsy
CNS & Neurological Disorders - Drug Targets Conference Report: 10th International Summer School of Neurology: Celebrating a Decade of Success: 5th July, 2015 – 9th July, 2015 | Eforie Nord, Romania
CNS & Neurological Disorders - Drug Targets AMPA Receptor Antagonists as Potential Anticonvulsant Drugs
Current Topics in Medicinal Chemistry The Doublecortin Gene Family and Disorders of Neuronal Structure
Central Nervous System Agents in Medicinal Chemistry ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Current Pharmaceutical Design Proceedings of the Regional Conference of the International Society for Adolescent Psychiatry and Psychology (ISAPP), a Joint Conference with 18<sup>th</sup> National Symposium of Adolescent Mental Health, Ankara, Turkey, November 21-24, 2013<sup>1</sup>
Adolescent Psychiatry Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets Dermatologic Effects of Psychopharmacologic Agents in the Pediatric Population
Current Psychopharmacology Distinct Forms of Spinal Cysticercosis: A Vietnamese Case Series
Current Medical Imaging Metabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes
Current Alzheimer Research Histamine as an Anticonvulsant Inhibitory Neurotransmitter
Current Neuropharmacology Revolutionary Impact of Nanodrug Delivery on Neuroscience
Current Neuropharmacology Novel Pyrimidine based Semicarbazones: Confirmation of Four Binding Site Pharmacophoric Model Hypothesis for Antiepileptic Activity
Central Nervous System Agents in Medicinal Chemistry Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases
Current Pharmaceutical Design Interleukin-1β Plays a Role in the Activation of Peripheral Leukocytes after Blood-Brain Barrier Rupture in the Course of Subarachnoid Hemorrhage
Current Neurovascular Research Molecular Structure of Ionotropic Glutamate Receptors
Current Medicinal Chemistry The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder
Current Drug Targets Neuroprotective Potential of Orientin with Antiepileptic Drugs against Pentylenetetrazole-induced Kindling Model and Evaluation of Behavioral Assessment in Mice
Current Enzyme Inhibition The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Current Pharmaceutical Design Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety